Hillsdale Investment Management Inc. - HARMONY BIOSCIENCES HLDGS IN ownership

Back to all holdings Add to watchlist

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2023$2,103,834
-6.9%
64,2000.0%0.19%
-7.2%
Q2 2023$2,259,198
-8.5%
64,200
-15.1%
0.21%
-1.4%
Q1 2023$2,468,340
-40.7%
75,6000.0%0.21%
-40.1%
Q4 2022$4,165,560–75,600–0.35%–
 Download
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders